from the Neandertal type specimen. Proc. Natl Acad. Sci. USA
35. Cavalli-Sforza, L. L., Menozzi, P. & Piazza, A. The History and
But a few exceptions do exist. Some reces-
96, 5581–5585 (1999). Geography of Human Genes (Princeton Univ. Press, Princeton,
sive mutations (mutations that influence a
25. Krings, M. et al. A view of Neandertal genetic diversity. Nature
person only if both copies of the gene are
Genet. 26, 144–146 (2000).
36. Risch, N., Burchard, E., Ziv, E. & Tang, H. Categorization of
26. Nordborg, M. On the probability of Neanderthal ancestry. Am. J.
humans in biological research: genes, race and disease. Genome
altered) are surprisingly common in specific
Hum. Genet. 63, 1237–1240 (1998). Biol. 3, 2007.1–2007.12 (2002).
27. Pääbo, S. Human evolution. Trends Cell Biol. 9, M13–M16
37. Tomasello, M. & Call, J. Primate Cognition (Oxford Univ. Press,
mutation patterns arises either from chance
28. Stringer, C. Modern human origins: progress and prospects.
38. Whiten, A. et al. Cultures in chimpanzees. Nature 399, 682–685
increases in frequency in isolated popula-
Phil. Trans. R. Soc. Lond. B 357, 563–579 (2002).
tions, such as in the Old Order Amish2, or
29. Deinard, A. & Kidd, K. Evolution of a HOXB6 intergenic region
39. Eichler, E. E. Recent duplication, domain accretion and the
from the protective effect of a deleterious
within the great apes and humans. J. Hum. Evol. 36, 687–703
dynamic mutation of the human genome. Trends Genet. 17,
mutation in a single copy, such as the genetic
30. Kaessmann, H., Wiebe, V., Weiss, G. & Pääbo, S. Great ape DNA
40. Enard, W. et al. Intra- and interspecific variation in primate gene
mutation that on the one hand causes sickle-
sequences reveal a reduced diversity and an expansion in
expression patterns. Science 296, 340–343 (2002).
cell anaemia, but on the other hand offers
humans. Nature Genet. 27, 155–156 (2001).
41. Enard, W. et al. Molecular evolution of FOXP2, a gene involved
protection against malaria3. These examples
31. Lewontin, R. C. The problem of genetic diversity. Evol. Biol. 6,
in speech and language. Nature 418, 869–872 (2002).
42. Jackson, A. P. et al. Identification of microcephalin, a protein
32. Kaessmann, H., Heissig, F., von Haesler, A. & Pääbo, S. DNA
implicated in determining the size of the human brain. Am. J.
ecology of a particular people are relevant to
sequence variation in a non-coding region of low
Hum. Genet. 71, 136–142 (2002).
understanding their present-day molecular
recombination on the human X chromosome. Nature Genet.22, 78–81 (1999). Acknowledgements
33. Harris, E. E. & Hey, J. X chromosome evidence for ancient
My work is funded by the Max Planck Society, the
For over 90 years, the association between
human histories. Proc. Natl Acad. Sci. USA 96, 3320–3324
Bundesministerium für Bildung und Forschung and the
Deutsche Forschungsgemeinschaft. I thank B. Cohen, H.
34. Yua, N. & Li, W.-H. No fixed nucleotide difference between
Kaessmann, D. Serre, M. Stoneking, C. Stringer, L.
Africans and non-Africans at the pyruvate dehydrogenase
Vigilant and especially D. Altshuler for helpful comments
E1 Ȋ-subunit locus. Genetics 155, 1481–1483 (2000).
results from faults in the DNA double helix(see, for example, the Online MendelianInheritance in Man database at www.-ncbi.nlm.nih.gov/omim/, which pro-
vides a catalogue of human genes and geneticdisorders). Is it then too extrapolative to
Aravinda Chakravarti* & Peter Little†
suggest that all diseases and traits, each of
*McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Jefferson Street Building, 2-109, Baltimore, Maryland 21287, USA
†School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, New SouthWales 2052, Australia (e-mail: p.little@unsw.edu.au)Is our fate encoded in our DNA? Is Watson’s genetic aphorism of human dis- What has been learnt about individual human biology and common diseases 50 years
ease really true? The excitement of genetics,
on from the discovery of the structure of DNA? Unfortunately the double helix has
and the perceived medical importance of the
not, so far, revealed as much as one would have hoped. The primary reason is an inability to determine how nurture fits into the DNA paradigm. We argue here that the environment exerts its influence at the DNA level and so will need to be understood before the underlying causal factors of common human diseases can be fully recognized.
approaches used successfully to identify single-gene diseases could simply be applied
“We used to think our fate was in our stars. Now we know, in large measure, our fate is in ourgenes.” J. D. Watson, quoted in Time magazine, 20 March 1989 (ref. 1).
morbidity and mortality, such as cancer,heart disease, psychiatric illness and the like. This would enable a boon for diagnosis,
The double helix, in its simplicity and laws of inheritance. So far, human geneticists understanding and the eventual treatment of
have been most successful at understanding
single-gene disorders, as their biological basis,
discovery provided the bridge between the
and thus presumed action, could be predicted
from inheritance patterns. Mendelian dis-
been slow, and only recently have there been
modern functional definition of genetics,
eases are typically caused by mutation of a some successes6. It is now appreciated that
single gene that results in an identifiable although genes are one contributor to the
biochemistry, cell biology and physiology.
disease state, the inheritance of which can
readily be traced through generations.
they contain must have properties that are
different from the more familiar, determin-
istic features of single-gene mutations.
about the role of genes in human disease.
Indeed, the underlying genes are likely to be
Notably, mutations in specific genes lead to
specific biological changes, and rarely do
major role, and mutations within these genes
mutations in multiple genes lead to an being common and imparting small geneticidentical set of characteristics that obey
effects (none of which are either necessary or
One gene, one disease
‘Mendelian inheritance’. Additionally,
Recognition that genes have a role in human
sequence diversity of mutations is large and,
Moreover, there is a suspicion that these
disease dates back to the rediscovery of the
rules that govern the inheritance of genes by
almost always rare, showing relatively and with the environment and lifestyle,
Gregor Mendel — the so-called Mendelian
although the molecular specificity of inter-
NATURE | VOL 421 | 23 JANUARY 2003 | www.nature.com/nature
2003 Nature Publishing Group
actions is unproven8. To complicate matters,
genetic variation and environment suggests
population differences that have led to health
ideas about genetics are simplistic; two in
disparities and, as is becoming more evident,
particular are the ‘bar code’ view of genetic
the incidence of these disorders can show sig-
diagnosis and the ‘right medicine for the
Interplay of DNA and environment
tially binary — either an adenine or guanine
The inability of geneticists to easily identify
base, or a cytosine or thymine base — at a
given position in the sequence. Unfortunate-
vindication of the importance of nurture.
ly, this leads to a tendency to define genetic
This is too simplistic; the influence of nature
individuality as a binary pattern, a so-called
and nurture cannot be neatly divided, as it is
‘bar code’ for each individual. Some genetic
clear that nurture is important to biology
variants convey susceptibility to a disease,
through its actions on DNA and its products.
but they typically convey risk rather than
The environment must affect the regulation
certainty of being afflicted with a condition.
of critical genes by some mechanism and so,
seen another way, mutations are not the only
have significant public health implications,
research reveals that despite having hetero-
intolerable, knowledge of likely outcomes,
acquired — a specific tumour develops only
with no certainty, only probabilities. Most
from altering the expression (activity) of
individuals, we suspect, are ill equipped to
specific sets of genes10. That is, a variety of
deal with the knowledge that they have a
50 per cent chance of succumbing to an ill-
change the activity of specific genes and,
ness; equally, society has had great difficulty
consequently, interrupt precise aspects of
in knowing how to respond to such informa-
cell metabolism. The regulation of circadian
tion, hence the concerns regarding genetic
discrimination13. The reality is that the
external environmental cues influence DNA
genetic bar code is weakly predictive and
individuals may find this threatening, life
enhancing or just irrelevant; in any event,
interacts with the environment, directly and
much work is needed to enable the predictive
indirectly, to predispose or protect us from
disease. If perturbations of multiple genes
contribute to a disorder, then the activities of
the recognition that medicine has to refocus
these genes can be affected by any combina-
on the individual. This has been the rallying
cry, particularly within the pharmaceutical
exposure altering their function. It is our
business, of pharmacogenomics (the applica-
opinion that genes have a stronger, maybe
tion of genome-scale understanding to the
even a pervasive, role in all diseases and
development of medicines), and there is no
traits, with the understanding that it is the
doubt that understanding of the variation
collective action of genes and nurture that
Figure 1 Studies of identical twins have revealed that
some conditions, such as psoriasis, have a strong genetic
exploded in the past 20 years14. The underpin-
Rather than dismissing the role of component and are less influenced by environmental and
ning idea is enormously attractive — if genetic
environment, our view embraces it directly,
lifestyle factors — identical twins are more likely to share
analysis of key DNA variations can be used to
these diseases. But other conditions, such as multiple
understand how individuals might respond to
term ‘genetic’. It also emphasizes the work
sclerosis, are only weakly influenced by genetic makeup
drugs, then it could be possible to eliminate the
that remains to be done to understand gene
and therefore twins may show differences depending on
difficult, sometimes lethal, hit-and-miss
regulation and, in particular, how genes and
their exposure to various environmental factors.
approaches to medication that are a necessary
feature of present medical practice.
Unfortunately, the influence of lifestyle is
human disease. Human beings are each to moderate in diabetes, heart diseases,
just as much a feature of drug response as it is
migraine and asthma, to high in disorders
of any other genetically influenced condi-
unique set of experiences. Both need to be
such as psoriasis12. Critically, the discordance
tion. The classic case of the influence of
understood to intervene effectively in disease
between identical twins — where twins show
drinking grapefruit juice on the levels of
different diseases despite being genetically
many drugs15 illustrated that there can be no
identical — illustrates the influence of exoge-
such thing as ‘the patient’, because the
Implications for medicine
nous factors, but does not prove the lack of
patient is living in a complex world that
What does this mean in practice? The assess-
influence of genes: of course, environmental
changes by the minute. Once again, predic-
ment of the quantitative role of genes in
factors over a lifetime affect an individual’s
tions for the population do not have the same
human traits is derived largely from studies on
identical and fraternal twins (Fig. 1). By this
measure, all common disorders have a ‘genet-
that all of the relevant genetic and environ-
Future challenges
ic’ basis, but the contribution varies from
mental factors are identified that lead to a
The challenges that lifestyle presents to
slight in some cancers and multiple sclerosis,
disease. Appreciating the relationship of
genetic studies are considerable. We believe
NATURE | VOL 421 | 23 JANUARY 2003 | www.nature.com/nature
2003 Nature Publishing Group
that the next 50 years will bring a genuine
an appreciation of both genetic and 8. Sullivan, P. F. et al. Analysis of epistasis in linked regions in the
revolution of far greater individual signifi-
environmental individuality; only then will
Irish study of high-density schizophrenia families. Am. J. Med. Genet. 105, 266–270 (2001).
cance than that delivered by genetics over the
individuals understand the meaning of their
9. Boyle, J. P. et al. Projection of diabetes burden through 2050:
past 50 years. This is because lifestyle can
impact of changing demography and disease prevalence in the
conceivably be analysed, and in so doing, it
United States. Diabetes Care 24, 1936–1940 (2001).
should be possible to develop a genuinely
10. Münger, K. Disruption of oncogene/tumor suppressor networks
during human carcinogenesis. Cancer Invest. 20, 71–81 (2002).
1. Jaroff, L. The gene hunt. Time 20 March, 62–67 (1989)
11. Panda, S., Hogenesch, J. B. & Kay, S. A. Circadian rhythms from
2. Arcos-Burgos, M. & Muenke, M. Genetics of population isolates.
flies to human. Nature 417, 329–335 (2002). Clin. Genet. 61, 233–247 (2002).
about how to identify lifestyle influences:
12. MacGregor, A. J. et al. Twins: novel uses to study complex traits
3. Aidoo, M. et al. Protective effects of the sickle cell gene against
and genetic diseases. Trends Genet. 16, 131–134 (2000).
such studies will have to be on an unprece-
malaria morbidity and mortality. Lancet 359, 1311–1312 (2002).
13. Wertz, D. C. Ethics watch. Nature Rev. Genet. 3, 496 (2002).
dented scale and one of the first of these, 4. Tishkoff, S. A. & Williams, S. M. Genetic analysis of African
14. Evans, W. E. & Johnson, J. A. Pharmacogenomics: the inherited
proposed to comprise 500,000 individuals in
populations: human evolution and complex disease. Nature Rev.
basis for interindividual differences in drug response. Annu. Rev.Genet. 3, 611–621 (2002).
the United Kingdom, has already started16. Genomics Hum. Genet. 2, 9–39 (2001).
5. Chakravarti, A. Single nucleotide polymorphisms: …to a future
15. Lown, K. S. et al. Grapefruit juice increases felodipine oral
These kinds of studies are a bold venture
of genetic medicine. Nature 409, 822–823 (2001).
availability in humans by decreasing intestinal CYP3A protein
into relatively uncharted territory and face
6. Carrasquillo, M. M. et al. Genome-wide association study and
expression. J. Clin. Invest. 99, 2545–2553 (1997).
substantial technical, biological and science-
mouse model identify interaction between RET and EDNRB
16. Wright, A. F., Carothers, A. D. & Campbell, H. Gene-
pathways in Hirschsprung disease. Nature Genet. 32, 237–244
environment interactions—the BioBank UK study. Pharmacogenomics J. 2, 75–82 (2002).
Scientifically, it is necessary to under-
7. Cox, N. J. Challenges in identifying genetic variation affecting
17. Stucker, I. et al. Genetic polymorphisms of glutathione S-
susceptibility to type 2 diabetes: examples from studies of the
transferases as modulators of lung cancer susceptibility.
calpain-10 gene. Hum. Mol. Genet. 10, 2301–2305 (2001). Carcinogenesis 23, 1475–1481 (2002).
culty here is the uncertainty surroundingboth terms in the equation; ideally, one set of genetic factors will interact with one set ofenvironmental influences to produce The double helix in clinical practiceidentical outcomes, but it is unknown
John I. Bell
whether this is always going to be the case. Afar more difficult relationship would exist if
The Office of the Regius Professor of Medicine, University of Oxford, Oxford OX3 9DU, UK
multiple genetic factors interacted with (e-mail: regius@medsci.ox.ac.uk) multiple environments to achieve the same outcome. The example of glutathione The discovery of the double helix half a century ago has so far been slow to affect S-transferase mutations, smoking and medical practice, but significant transformations are likely over the next 50 years. incidence of lung cancer17 shows it is possible Changes to the way medicine is practised and new doctors are trained will be
to detect some interactions, but it is unclear
required before potential benefits are realized.
how, or even if, statistical methods might bedeveloped for addressing the more complex
“It is much more important to know what kind of patient has a disease than to know what kind ofdisease a patient has.” Caleb Parry, 18th century physician, Bath.
taking these projects is human psychology; theconsequences of smoking have been known
This was despite the convictions of at least
for many decades, but people still smoke.
one distinguished statistical geneticist who
basic framework that would developinto the field of molecular genetics. The
argued against the causality of this observa-
turn knowledge into practical outcomes must
tion, implying that a common genetic factor
be an increasing focus of attention for both
caused both lung cancer and a predilection
influence on our understanding of biological
Psychology is also in play in the initial
significant heritable component, it was soon
researchers, funding agencies and politicians
recognized that the characterization of the
health care at the time of their fiftieth
there is great risk implicit in undertaking a
anniversaries than has the double helix, its
hugely expensive project with complex out-
provide remarkable opportunities for clinical
slower transition from discovery to clinical
come. People would like to live in a simpler
medicine, potentially altering the way disease
world, with simpler decisions, but the vision
was understood, diagnosed and treated.
medical disciplines. Progress has been slow,
complete, as much will be known about the
cations to medicine, the development of but mounting evidence suggests that, while
origins of human disorders as can be discov-
significant genetic advances relevant to public health and antibiotics produced
clinical practice could take generations. This
important healthcare outcomes in the past
genetic studies. Perhaps more important, the
is in marked contrast to many other medical-
50 years, the next 50 are likely to belong to
beginnings of a new medicine will emerge,
ly related discoveries that occurred around
The potential impact of genetics on clini-
rapidly into clinical practice. For instance,
genetic uniqueness and personal choices that
the development of penicillin by Ernst Chain
observers5 who believe that the positive
are the very essence of individual lives.
and Howard Florey in 1941 was saving predictive value of genetic testing for most
If we are collectively bold in our present
thousands of lives within months of their
common disease genes will be insufficient to
decisions and accept the risk of action, a
discovery of how to efficiently produce the
provide the beneficial effects seen with
antibiotic2. Discoveries relating to disease
single-gene disorders, which affect only a
guide, not a place of last resort. If the past
aetiology, such as the recognition in 1950 of a
50 years has seen the revolution of DNA, then
relationship between smoking and lung can-
advocates of genetics argue, on the other
the revolution cannot be completed without
cer, have had a profound effect on mortality3.
hand, that our understanding of disease is
NATURE | VOL 421 | 23 JANUARY 2003 | www.nature.com/nature
Litigation as the Great Equalizer: New Fulbright & Jaworski Survey Finds Nearly 90% of U.S. Corporations Engaged in Lawsuits; Average $1 Billion Company in U.S. Faces 147 Cases at a Time Unrelenting/unpredictable costs make litigation budgeting the bane of corporate counsel – 40% don’t quantify dispute spending; for businesses keeping track, litigation costs an average of $8
Muscular dystrophy Introduction Muscular dystrophy (MD) is a group of inherited muscle diseases in which muscle fibers are unusually susceptible to damage. Muscles, primarily voluntary muscles, become progressively weaker. In the late stages of muscular dystrophy, fat and connective tissue often replace muscle fibers. Some types of muscular dystrophy affect heart muscles, other involuntary